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Abstract 
 
This report details the feasibility of a field deployable DNA analyzer.  Steps for 
swabbing cells from surfaces and extracting DNA in an automatable way are 
presented.  Since enzymatic amplification reactions are highly sensitive to 
environmental contamination, sample preparation is a crucial step to make an 
autonomous deployable instrument.  We perform sample clean up and concentration 
in a flow through packed bed.  For small initial samples, whole genome amplification 
is performed in the packed bed resulting in enough product for subsequent PCR 
amplification.  In addition to DNA, which can be used to identify a subject, protein is 
also left behind, the analysis of which can be used to determine exposure to certain 
substances, such as radionuclides. Our preparative step for DNA analysis left behind 
the protein complement as a waste stream; we determined to learn if the proteins 
themselves could be analyzed in a fieldable device. We successfully developed a two-
step lateral flow assay for protein analysis and demonstrate a proof of principle 
assay.   
 
Introduction/Background 
DNA is contained in: blood, semen, skin cells, tissue, organs, muscle, brain cells, 
bone, teeth, hair, saliva, mucus, perspiration, fingernails, urine, feces, etc. Only 
0.1% of DNA (~3 million bases) differs from one person to the next. However, 
sufficient differences exist in this 0.1% to allow identification of individuals based on 
their DNA.  A DNA profile is analogous to traditional fingerprint analysis.  Short 
Tandem Repeat (STR) DNA analysis is the standard used by law enforcement 
agencies.  Comparison of an unknown sample to an individual’s STR pattern gives 
very high uniqueness (1013-1015).  
 
A small portable DNA tester, designed specifically to test DNA samples is the goal of 
this work. The concept has the following aspects: automated sample preparation, the 
device for the DNA analysis, and the PCR based analysis of DNA signatures. Our 
research investigates the fundamental limits of sample type, sample acquisition and 
analysis necessary for a field deployable human forensics identification device. 
 
A sample of interest will be collected and input into the device.  The sample from the 
input swab/tissue sample will then be combined with an equal volume of high-salt 
lysis/purification solution and passed through a lyser and into an extractor. The 
extractor is able to concentrate DNA into a small volume while also purifying it. After 
the initial adsorption from the lysis/purification solution onto the extractor, the 
adsorbed DNA is washed and then dried. The reaction buffer for the whole genome 
amplification (WGA) is then passed into the chamber where the DNA is immobilized 
on the surface.  Amplification is performed directly on the DNA adhered to the 
surface.  The DNA extractor is included to provide both purification and 
concentration. WGA and PCR are very powerful techniques, but the enzymatic 
reactions can be inhibited by several environmental contaminants if the sample is 
not purified. By performing in-situ PCR in the same concentration/purification 
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 chamber we will be able to amplify approximately 75% of the DNA, compared to 
approximately 50% that is currently available for PCR when the sample is amplified 
in a different chamber.  Development of the purification and amplification chambers 
is currently being developed under the scope of a different project.  This project 
leveraged the reaction chambers for future integration into an autonomous device. 
 
The focus of this paper is to report on the feasibility of automating all the necessary 
steps and proving the whole genome amplification of DNA in the packed bed 
(purification and concentration chamber). 
 
Research Activities 
 
During this six month research project we focused on 
• Sample acquisition and preparation:  Isolating the cells rapidly and using a 
method that could be automated.   
• Whole-genome amplification–WGA increases amount of DNA available for 
analysis, starting from just a few cells determining how quickly can we 
amplify DNA enough to perform analyses 
• Protein analysis - In addition to the above areas which focused on analyzing 
DNA (answering who was present) we also devised a technique to identify 
what they had been doing, by analyzing proteins which were a waste stream 
from the DNA extraction steps.  Although not included in the scope of work in 
the original proposal we were able to successfully demonstrate proof of 
principle. 
 
Results/Technical Outcome 
 
Sample Acquisition and Preparation 
Sample acquisition from surfaces is most often performed by swabbing.  To 
standardize the swabbing technique we developed a modified tube that essentially 
wrings out the swab as the user extracts it from the lysis solution.  After swabbing a 
surface the user inserts the swab through a hole in the top of a centrifuge tube into 
the lysis solution (Figure 1a).  The swab is then mildly agitated in the solution and 
the cells are removed from the swab to the lysis solution.  As the swab is withdrawn 
through the top the inserted feature (Figure 1b and c) wrings out the swab leaving 
more solution (containing DNA) in the tube for analysis. 
 
 
Figure 1:  a) Insertion of swab with adhered DNA into lysis solution,  b) Withdrawal 
of swab through modified tube, c) view of open tube to show foam structure to 
maximize solution returned to vial. 
 
When working with small samples, sample preparation becomes highly important.  
Even the slightest contamination can alter the outcome of a reaction, or inhibit it 
altogether.  Traditional methods of cleaning samples, such as organic extraction 
followed by ethanol precipitation, or lysing and then passing through a column are 
known to lose a relatively large amount of sample.  This is particularly detrimental 
when the sample was limited in the first place. 
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 We present a technique that couples the use of whole genome amplification with a 
packed silica column. The most effective method of sample purification and 
extraction is to simply mix the cells once in solution using the above swabbing 
technique with a denaturation solution.  The sample is loaded and bound to the 
column.  While bound, the DNA is then washed and amplified, making use of all the 
available starting material.  After amplification, the sample can be eluted for further 
analysis.  Although some material may be lost, we demonstrate that successful PCR 
analysis can still be performed with as little as 20 pg of DNA.  Parallel samples in 
which DNA was simply washed in the column, as in traditional clean up protocols, 
could not be successfully analyzed. 
 
Whole Genome Amplification 
Since only small initial amounts of DNA will be present in the samples of interest 
whole genome amplification is necessary to increase the amount of DNA available for 
analysis.  Before this research all phi 29 amplification was performed for 16 hours.  
Generating a calibration curve for amplification time involved quantifying DNA by 
picogreen analysis.  Details of this process are given in the appendix.  In summary, 
sufficient DNA is generated after 4 hours of amplification.  Study of times shorter 
than four hours were not as consistent and not correlation between time and amount 
of DNA could be generated.  For example, starting with 2ng of DNA and amplifying 
for just 15 minutes resulted in approximately 500 ng of DNA. 
 
Figure 2 below shows the successful amplification of DNA as a function of reaction 
time for two different initial amounts of DNA.  Decreasing the reaction time from 16 
hours to just 4 hours still produces sufficient DNA for subsequent analysis. 
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Figure 2:  Calibration curve for phi 29 reaction as function of reaction time for two 
starting amounts of DNA.  a) Initial amount of DNA is 10fg, b) initial amount of DNA 
is 1ng. 
 
WGA in clean up column 
Initial experiments in our lab were performed using larger amounts of DNA to 
test the feasibility of whole genome amplification within a column.  Despite the large 
surface area the concentration of reagents was the same as in a centrifuge tube.  
Some studies have found that due to the increased surface area reagents will be lost 
by adhesion to the surface.  Amplification in a packed bed was successful.  Reactions 
containing 5, 2 and 1 ng of DNA produced positive Phi29 results followed by PCR 
100% of the time.  This set of experiments demonstrated that the packed bed is able 
to both purify (by removal of the chemical inhibitor guanidine isothiocyanate which is 
used as a denaturation solution) and concentrate the input DNA solution.     
For practical applications of these methods, we are interested in much smaller 
initial quantities of DNA. By performing WGA of DNA bound to the silica beads in the 
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 column we should have a much lower limit of detection than if the DNA had to first 
be eluted.  After verifying amplification in the presence of the silica beads, we tested 
the following total amounts of DNA: 0.5, 0.05 and 0.02 ng DNA. In side by side 
experiments, samples were washed and amplified within the column, or washed, 
eluted and amplified outside of the column.  DNA prepared in both fashions was then 
amplified by PCR.   Results from this experiment are shown in Figures 3 and 4.  In 
Figure 3, whole genome amplified samples can be seen, prepared both in and out of 
the column.  Although results appear similar at this stage, Figure 4 shows that 
successful PCR analysis is much more difficult on samples that had been eluted from 
the column before amplification.  In our experiments, we performed five PCR 
analyses on each quantity of DNA (since the DNA becomes diluted upon elution), but 
had only a 20% success rate on the highest amount of starting material and no 
success on the other amounts of starting material (see Table 1) 
 
 
Figure 3:  Gel showing positive amplification of DNA when amplified on the surface of 
the beads in the packed column.  Lanes are: (1) Empty, (2) 100 bp ladder, (3) 50pg 
sample - phi29 mix flushed out of bed through frit (before eluting step), (4) 50pg 
sample - eluted DNA(TE heated at 72C for 3min, flushed out of bed w/beads), (5) 
20pg sample - phi29 mix flushed out of bed through frit (before eluting step), (6) 
20pg sample - eluted DNA(TE heated at 72C for 3min, flushed out of bed w/beads), 
(7) Empty, (8) phi29 positive control - 50pg DNA amplified via phi29 rxn in tube, (9) 
phi29 positive control - 20pg DNA amplified via phi29 rxn in tube, (10) phi29 
negative control - H2O as "template" in phi29 rxn in tube, (11) MT-PCR positive 
control - stock K562 (10ng/ul) as "template" in MT-PCR recipe, (12) MT-PCR 
negative control - H2O as "template" in MT-PCR recipe 
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Figure 4:  Agarose gel generated from eluted DNA (traditional clean up column).  
Lanes are: (1) Empty, (2) 100 bp ladder, (3-7) 50pg sample only PCR band in lane 6 
(1 out of 5 successful PCR), (8) Empty, (9-13) 20pg sample, no successful PCR 
products 
 
 % successful PCRs 
Amount of DNA Within column External to column
2 ng 100 100 
0.5 ng 100 100 
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 0.05 ng 100 20 
0.02 ng 100 0 
Table 1:  Comparison of limit of detection for DNA amplified in packed bed versus 
DNA eluted from packed bed and amplified on the benchtop (traditional clean up 
column) as determined by successful PCR amplifications subsequent to WGA. 
 
These results indicate the feasibility of combining clean-up and whole genome 
amplification into a single step.  When performed separately, much larger amounts 
of starting material must be used in order to compensate for significant losses during 
clean-up. By amplifying the sample prior to elution, these losses are no longer a 
problem. 
This technique could prove to be very useful for forensic science applications.  A 
great deal of effort is currently being directed at using the DNA contained in a single 
fingerprint.  Most researchers found that a single print contains anywhere from less 
than 40 pg to 2 ng.  In a previous paper, we demonstrated successful amplification 
of this amount of material, but many samples obtained for analysis require clean up 
from environmental contaminants.  This is easily possible given the above technique, 
which was successful with as little as 20 pg of DNA. 
 
Much of law enforcement DNA analysis is performed by STR analysis.  While 
extremely efficient when analyzing a single subject this technique typically fails when 
the sample contains DNA from many subjects.  However, since this is the standard 
that law enforcement uses we will work on modifying this technique for use with 
multiple subjects.  Alternatively Alu PCR reactions can identify a subject’s ethnicity.  
However, more than 100 reactions are required to accomplish this.  The number of 
reactions is far too high for this particular application, plus it is unknown whether 
this analysis would yield a unique identification of a single individual from a pool of 
subjects of the same ethnicity.  Haplotypes are combinations of alleles that a 
population shares. Recently researchers have constructed a haplotype map of the 
human genome. After much research into using haplotype analysis for identification 
we determined that the most appropriate analysis technique for identification is still 
STR analysis.  Several companies are investing in this area and their developments 
will continue to be monitored and incorporated as the technology matures.  
 
Protein analysis 
In addition to DNA, which can be used to identify a subject, protein analysis 
can be used to determine exposure to certain substances, such as radionuclides. Our 
preparative step for DNA analysis left behind the protein complement as a waste 
stream; we determined to learn if the proteins themselves could be analyzed in a 
fieldable device.  
A considerable effort has been made to develop a number of diagnostic 
assays for protein recognition using antibody based detection mechanisms.  Similar 
to the development of such lateral flow assay test strips found in most standard 
pregnancy tests we developed the use of a similar devise that would detect for 
proteins present in human cells as a result of a hazardous material exposure.  Our 
model uses identifiable HeLa cells transfected with the human chorionic gonadotropin 
(hCG) gene that have hCG glycoprotein expression normally produced by pregnant 
women and can be detected through a lateral flow antibody binding pregnancy tests 
to confirm protein expression.  Human chorionic gonadotropin (hCG) is a 
glycoprotein hormone produced by normal trophoblast cells of the placenta and 
sometimes produces by the pituitary gland.  During pregnancy these hormonal levels 
increase and a high level of protein expression is excreted in blood and urine 
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 samples of the individual.  This glycoprotein hormone is therefore used as a 
precursor to determine whether a woman is pregnant.  The First Response™ 
pregnancy test uses an immunoassay liquid chromatography test strip to detect for 
greater than 15-25mIU of hCG protein levels in urine to confirm pregnancy. 
Our intention is to demonstrate an effective method of cellular pickup, lysis, 
and lateral flow protein detection method in an easy process that could be self 
administered as a diagnosis tool in large scale applications for quick diagnosis of 
human infection and other methods of harmful agent detection in biochemical 
materials. 
 
Lysis of cells for protein analysis 
Several lysis solutions were tested using the least amount of human or mechanical 
manipulation to detect total protein concentration.   No mechanical steps, such as 
vortexing or centrifuging were considered.  Chemical lysis was the only method 
considered for implementation in a fieldable device. Figure 5 compares lysis 
efficencies of Hela cells pre-transfection for CellLytic lysis/extraction solution both 
with and without 5mg/ml lysozyme. The inclusion of lysozyme in the lysis solution 
increased the amount of lysed proteins 3 fold, see Figure 5. 
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Figure 5: Cell lysis of 105 Hela cells for total  protein quantification (mg/ml) using 
different lysis solutions. Water was run as a control for the quantification assay. 
 
Rapid One Step Detection Assay 
We have developed a simple process for isolating cells from a surface and lysing 
them. This one step method allows us to swab cells off of a glass slide, insert the 
swab into a lysis buffer, and identify the presence of a particular protein using a 
lateral flow assay. To accomplish this, we engineered a human epithelial cell line that 
expresses the human chorionic gonadotropin protein (HCG), which is the protein 
tested for in lateral flow pregnancy tests. HCG cells (106cells) were dropped on 
cleaned microscope slides (see Appendix for details). The cells were then washed in 
3X PBS solution. The slides were then swabbed directly with the chromatography 
paper at the end of the test strip (Figure 6a).    
 
The test strip chromatography paper was then placed in a cap containing the lysis 
buffer, which was quickly absorbed by the paper. The solution rapidly lyses the cells, 
releasing the HCG protein, which then reacts on the test strip with a total elapsed 
experimental time of ~5 minutes (Figure 6b).  
 
Figure 7 shows the pregnancy test strips used for both the non-HCG-expressing 
swabbed cells (left) and the HCG-expressing cells (right). The arrows indicated with 
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 a (1) are the positive controls for the test.  Although fainter for the HCG-expressing 
cells the control line is present for both samples, confirming that the assay is 
performing as expected. Arrows (2) also show a positive test line for the HCG-
expressing cells (right) but no positive test line for the non-HCG-expressing cells.  
We quantified the level of HCG in the cells by standard ELISA assays, and found that 
the protein lysis protocol reacting while migrating on the chromatography paper was 
able to release 80% of the protein in the cells, based on the published sensitivity of 
the lateral flow HCG test kit that we used (Figure 7).  
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Figure 6:  a) A droplet containing 106 cells expressing HCG is swabbed from a glass 
slide using stiff chromatography paper. The cells adhere to the rough paper. b) The 
swab with cells attached is inserted in the lysis/carrier solution. The cells are lysed 
while the solution travels up the chromatography paper. By the time it reaches the 
test band, all reactions have occurred. c) Schematic of swab and lysis solution.  
Notch on swab tip positions swab tip for storage (pre-use) or lysis depending on 
orientation and alignment with reservoir. 
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Figure 7:  Pregnancy test strips with arrows showing positive control lines for both 
the non-HCG-expressing swabbed cells (left) and the HCG-expressing cells (right) 
(1). Arrows also show a positive test line for the HCG-expressing cells (right) but no 
positive test line for the non-HCG-expressing cells. 
 
For both of these experiments the cells were swabbed from a microscope slide using 
just chromatography paper as the swab.  A single lysis and reaction step was 
performed once the chromatography paper was inserted into the lysis reagent 
reservoir.  By the time the solution has flowed along the chromatography paper to 
the test band all reactions have occurred and a positive result can easily be detected.   
 
We have demonstrated that the notion of a simple, two-step assay is viable for the 
detection of exposure to biological or radiological agents.  The change in expression 
of proteins is an easy noninvasive method when combined with lateral flow assays.  
Lateral flow assays are easy to use tools for first responders to assess human 
exposure to differing agents.  Our one step method reduces a first responder’s level 
of intervention necessary to perform a test (mechanical steps) without decreasing 
accuracy while providing a rapid response to help with triaging victims. 
 
Publications / Records of Invention 
 
This work resulted in 2 ROIs and 2 papers that are in preparation for submission to 
refereed journals. 
 
 
Exit Plan 
 
Various government agencies have expressed interest in our techniques and we are 
currently pursuing funding opportunities in this arena. 
 
 
 
Summary 
 
We have demonstrated that the notion of a simple, one-step assay is viable for 
the identification of subjects and detection of exposure to hazardous materials.  
Using DNA analysis a subject can be identified. Often a responder only has a very 
small amount of starting material (<10 cells).  By subjecting the DNA to our 
procedure to maximize DNA recovery (wringing out the swab) and performing whole 
genome amplification there becomes enough DNA for subsequent analyses.  Whole 
genome amplification using phi29 has been shown by many to produce an accurate 
representation of the starting material, making it a viable first step in sample 
analysis. When performed in a column it provides a useful means of cleaning and 
analyzing very small amounts of DNA. We also determined that the change in 
expression of proteins is an easy noninvasive method when combined with lateral 
flow assays.  Lateral flow assays are easy to use tools for first responders to assess 
human exposure to differing agents.  Our one step method reduces a first 
responder’s level of intervention necessary to perform a test (mechanical steps) 
without decreasing accuracy while providing a rapid response to help with triaging 
victims. 
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 Appendix 
Protocol for PicoGreen Quantitation 
In order to quantify the success of the MDA reaction PicoGreen analyses (Molecular 
Probes, Eugene, OR) were performed.  To generate the curves for greater than 4 
hours of amplification the following concentrations of 10ng/µL K562 hgDNA were 
amplified with the phi29 protocol: 10fg/ul, 100fg/ul, 1pg/ul, 10pg/ul, 100pg/ul, 
1ng/ul.  Each DNA concentration was amplified in a Phi29 reaction with a 154µL total 
volume.  25µL of DNA sample was removed from each reaction tube at the desired 
time point during the amplification period.  The removed samples were heat 
denatured at 65C for 10 minutes and cooled to 4C. Following Phi29 protocol, 
PicoGreen quantitation analysis was performed.   
 
Detection and quantitation of amplified amounts of DNA was performed using 
PicoGreen dsDNA quantitation reagent.  The following are included in the Molecular 
Probes’ PicoGreen dsDNA Quantitation Kit (P/N: P-11496): 20X TE (200mM Tris-HCl, 
20mM EDTA, pH 7.5) buffer; PicoGreen dsDNA quantitation reagent; Lambda DNA 
standard (100µg/mL in TE).  10mm x 10mm polystyrene cuvettes from Turner 
Designs were used in the experiment (P/N: 7000-957).  First, the 20X TE buffer was 
diluted 20-fold with distilled water for a final 1X TE working solution.  An aqueous 
working solution of the PicoGreen reagent was prepared by a 200-fold dilution using 
1X TE.  This reagent was protected from light and was used within a few hours of 
preparation.  A high range and low range standard curves were prepared from 
Lambda DNA in order to calculate the concentration of DNA in each sample.  A 
2µg/mL working solution of 100µg/mL Lambda DNA was prepared by a 50-fold 
dilution in 1X TE.  A five-point high standard curve (1µg/mL, 100ng/mL, 10ng/mL, 
1ng/mL, 0ng/mL) was prepared by diluting the 2µg/mL working solution with 1X TE.  
A seven-point low standard curve (25ng/mL, 10ng/mL, 2.5ng/mL, 1ng/mL, 
250pg/mL, 25pg/mL, 0pg/mL) was prepared by diluting the 1µg/mL DNA stock 
solution prepared in the high standard curve with 1X TE.  To each tube that 
contained a final sample volume of 1.0mL, 1.0mL of the working solution of 
PicoGreen reagent to make the total volume of 2.0mL.  All tubes were mixed well 
and protected from the light.  The sample fluorescence was measured using a Turner 
Designs TD-700 Fluorometer (Model # 7000-009) at 520nm while exciting at 480nm.  
The fluorometer’s gain was set so that the sample containing the highest DNA 
concentration had a fluorescence value near the fluorometer’s maximum.  Each 
standard solution was read three times and the average was calculated.  The 
fluorescence value of the reagent blank(1X TE) was subtracted from each sample’s 
average reading.  The corrected readings were used to generate standard curves of 
fluorescence versus known DNA concentration.  A linear relation was observed before 
proceeding to measuring the experimental DNA samples.  The experimental DNA 
samples were diluted 500-fold with 1X TE to a final volume of 1.0mL.  Three 
separate dilutions of each initial DNA concentration sample were made in order to 
get a more precise average fluorescence value.  To each tube, 1.0mL of the working 
solution of PicoGreen reagent was added.  The fluorescence of the DNA samples was 
measured with the instrument calibrated to the low standard curve first.  Any 
samples that had higher fluorescence intensity than the fluorometer’s maximum for 
the low standard curve was measured after the instrument was calibrated to the high 
standard curve.  The fluorescence value of the reagent blank (1X TE) from the 
corresponding standard curve was subtracted from each sample.  The DNA 
concentration of the experimental samples was determined from the standard curves 
generated.           
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 hCG gene transfection into HeLa cells: 
Bacterial strains, cultures, and plasmids 
 
 The E. coli host strain DH10B was used to grow up the pOTB7 plasmid (1815 
bp) that contained the human chorionic gonadotropin (hCG) gene (#5431911 
I.M.A.G.E. Consortium/LLNL).  The hCG gene beta polypeptide coding region (931 
bp) had been inserted in the pOTB7 plasmid between the EcoRI and XhoI restriction 
enzyme sites.  Bacteria were grown overnight at 37°C on Luria-Bertani (LB) agar 
plates containing chloramphenicol (100µg/ml), and single colonies of the overnight 
culture were picked and grown in 3ml of LB liquid media with chloramphenicol 
(100µg/ml) for ~8h at 37°C with vigorous shaking (250rpm).  Then 200µl of this 
liquid culture was used to inoculate 100ml of LB media with chloramphenicol 
(100µg/ml) and was grown up overnight for 16h at 37°C with vigorous shaking 
(250rpm).  The pOTB7 plasmid was isolated using a QIAGEN Plasmid Purification 
Maxi Kit (QIAGEN, Valencia, CA) and was resuspended in 60µl TE buffer, pH 8.0, to 
yield a vector DNA concentration of 6.209µg/µl. 
 
 The purified pOTB7 vector was the template used in PCR amplification of the 
hCG gene.  Oligonucleotide primers hCGforward (5’-GCC GCC GCC ATG GAG ATG 
TTC CAG GGG CTG-3’) and hCGreverse (5’-TTA TTG TGG GAG GAT CGG GGT GTC 
CG-3’) were used (Sigma Genosys, The Woodlands, TX) and designed to include the 
KOZAK sequence to enhance hCG gene translation efficiency.  The hCGF and hCGR 
primers were diluted to 200µM in TE buffer.  The PCR mixture contained 1µl of total 
template DNA, 4µM of each of the primers, Buffer A (Roche, Basel, Switzerland) with 
1.0mM MgCl2 at pH 8.3, 200µM of dNTP (Roche), 10µl of 1X GC Rich Solution 
(Roche), and 2U of FastStart Taq DNA Polymerase (Roche), in a total volume of 50µl.  
After a denaturation step at 95°C for 5min, PCR was run for 35 cycles at 94°C for 
60sec and 60°C for 30sec, followed by a final elongation step at 72°C for 3min.  
Samples were analyzed on 2% agarose gels with 1X TBE buffer at 100V.  Amplified 
products were purified using a QIAquick PCR Purification Kit (QIAGEN) and 
resuspended in 30µl of 10mM Tris-Cl, pH 8.5. 
 
Transformation 
 
 The hCG gene amplified from the pOTB7 plasmid was ligated into the shuttle 
vector of choice, the pTargeT vector (Promega, Madison, WI).  The pTargeT vector 
(5670 bp) had resistance to ampicillin and the antibiotic G-418, and it contained the 
β-galactosidase coding sequence, making blue/white screening possible.  Additionally 
the pTargeT vector had 3’-thymidine overhangs at the hCG gene insertion site, 
increasing the probability of successful ligation of the hCG insert in the proper 
orientation.  The hCG gene was ligated into the shuttle vector using the pTargeT 
Mammalian Expression System (Promega).  The ligation reaction was carried out 
with 1µl T4 DNA Ligase (3 Weiss units), 1µl of 10X T4 DNA Ligase Buffer, 60ng of 
pTargeT vector, and 7µl of hCG amplified product.  Control ligation reactions were 
also run with positive control insert DNA (542bp) and without insert DNA altogether. 
All samples were incubated at 4°C overnight. 
 
 Following the ligation of the hCG gene into the pTargeT vector and the 
controls, JM109 High Efficiency Competent Cells (Promega) were transformed with 
each of the three ligation reaction products and an uncut plasmid to measure 
transformation efficiency.  The uncut plasmid used was the pSP72 vector with 
resistance to ampicillin at an amount of 1.0ng per 1ml of total transformation 
reaction volume.  Protocol outlined by Promega was followed as mixtures of 50µl of 
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 JM109 cells and 2µl of ligation reaction product were iced for 20min, heat shocked 
for 45sec at 42°C, and then incubated in 950µl of SOC medium, pH 7.0, for 1.5 hours 
at 37°C with shaking (~200rpm).  Then 100µl of each transformation reaction was 
plated on duplicate antibiotic plates.  LB plates were used with ampicillin (100µg/ml), 
and 100µl of 100mM IPTG and 20µl of 50mg/ml X-Gal were added topically to the 
plates.  The IPTG and X-Gal were allowed to absorb into the LB+amp plates for 
30min at 37°C.  Plated transformations were incubated at 37°C overnight and the 
blue and white colonies were counted the next day. 
 
 Though low numbers of blue and white colonies were observed after the 
transformation, at least one blue and one white colony of all plates were picked and 
replated, if possible, on new sets of LB+amp plates (100µg/ml) that were left to 
incubate overnight at 37°C.  A PCR screen using the aforementioned PCR protocol 
was performed to ensure the transformed cells that were replated actually contained 
the hCG gene ligated into the pTargeT vector.  The replated samples were then 
grown up in 3ml of liquid LB media with ampicillin (50mg/ml) at 37°C for ~6 hours 
with shaking (250rpm). The pTargeT vector containing the hCG gene was isolated 
using a QIAfilter Plasmid Purification Maxi Kit (QIAGEN) and was resuspended in 60µl 
10mM Tris-Cl, pH 8.5, to yield a vector DNA concentration of 4.433µg/µl. 
 
Transfection 
 
 HeLa cells were cultured in preparation for the transfection with the pTargeT 
vector with the hCG gene of interest. The cells were grown in a T-75 flask and then 
were to be transferred into 6-well plates for further growth and eventual 
transfection.  Existing HeLa media (89% RPMI 1640, 10% heat-inactivated FBS, 1% 
200mM L-Glutamine) was removed from cells and 3ml of trypsin was added to 
release adherent cells from the sides of the container.  After incubating for 3min at 
37°C, 5% CO2, the flask was tapped to loosen the cells and 3ml of warm HeLa media 
was added to the cells.  Cell counts were determined by using a hemocytometer 
after adding Trypan Blue to an aliquot of the cell culture to mark all dead cells.  The 
6ml of cells and media were transferred from the flask to a falcon tube, spun at 
1,000rpm for 5min, and the pelleted cells were resuspended in media to a desirable 
concentration. 
 
Prior to transfection, 1x106 HeLa cells were plated in antibiotic-free media 24 
hours in advance so as to achieve maximum confluence.  Transfection was carried 
out using the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) and 10µg total 
of pTargeT vector with the desired hCG gene insert within each well of cells to be 
transfected. [reference Alice Chen’s paper & transfection protocol]  Cells were 
incubated at 37°C, 5% CO2 for various lengths of time, with hCG protein expression 
being measured both qualitatively and quantitatively by means of pregnancy test 
strips (First Response) and an hCG-specific ELISA (Abazyme, Needham, MA), 
respectively. 
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